Publication date: Jan 30, 2025
Nonpharmaceutical public health interventions, such as contact tracing (CT), have been widely implemented worldwide to mitigate the spread of coronavirus disease 2019 (COVID-19). This study investigated the association between CT activity and COVID-19 cases, as well as the impact of timely contact with positive cases on hospitalizations in the Veneto region in northeastern Italy. Data sources included a CT-focused questionnaire, regional daily CT activity data, and a regional database of daily COVID-19 cases, hospitalizations, and intensive care unit (ICU) admissions. Negative binomial regression models were used to assess associations between CT activity and the number of positive cases, the number of hospitalizations, the time to contact cases, the number of positive cases traced, and the number of CT operators. Different organizational models (OMs) were compared in terms of their effectiveness. Hospitalization rates decreased by 54% when index cases were contacted within 0-1 days compared with a five-day delay in the first period. During periods of increasing case numbers, hospitalizations decreased to 8% for contact ranges of 0-1 and 2-4 days. The increase in CT activity showed a 60% increase in daily activity per 100 cases in the third period, excluding external CT activities. These results emphasize the critical role of prompt and effective CT in controlling the spread of infectious diseases and reducing the burden on health care systems. Further research is warranted to explore the potential benefits and limitations of different organizational models in the context of contact tracing and public health management, as well as in a cross-cultural comparison.
Open Access PDF
Concepts | Keywords |
---|---|
Coronavirus | contact tracing |
Daily | COVID-19 |
Hospitalizations | hospitalizations |
Italy | organizational models |
Nonpharmaceutical | pandemic control |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | contact tracing |
disease | MESH | COVID-19 |
disease | MESH | Data sources |
disease | IDO | role |
disease | MESH | infectious diseases |
disease | MESH | tuberculosis |
pathway | KEGG | Tuberculosis |
disease | MESH | sexually transmitted infections |
disease | MESH | measles |
pathway | KEGG | Measles |
pathway | REACTOME | Reproduction |
disease | MESH | infection |
disease | IDO | susceptibility |
drug | DRUGBANK | Tretamine |
disease | MESH | emergencies |
disease | IDO | symptom |
disease | IDO | process |